Two further vaccines licenced for use in Hungary

Hungary's medicines authority OGYEI has granted licences for use to the Chinese CanSino coronavirus vaccine and Covishield, AstraZeneca's vaccine produced in India, the chief medical officer said on Monday. Cecilia Muller, speaking at the daily press conference of the coronavirus operative board, said she hoped that a greater choice of vaccines would bolster the country's vaccination programme, adding that "the jab is the only way out of the epidemic". Muller said that 1.59 million Hungarians, 16 percent of the population, had received at least their first shot, but warned that the third wave of the pandemic was "still extremely dynamic", with the highly infectious British coronavirus variant causing 90 percent of the new cases.